Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease

References

• White JV, Ryjewski C. Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification. Semin. Vasc. Surg.20(1), 54–61 (2007).
   PubMed Web of Science ®Google Scholar
• Grenacher L, Saam T, Geier A et al. PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA). Rofo.176(9), 1302–1310 (2004).
   PubMedGoogle Scholar
• Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J. Vasc. Interv. Radiol.12(8), 935–942 (2001).
   PubMed Web of Science ®Google Scholar
• Cejna M, Thurnher S, Illiasch H et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J. Vasc. Interv. Radiol.12(1), 23–31 (2001).
   PubMed Web of Science ®Google Scholar
• Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch. Surg.136(2), 221–228 (2001).
   PubMedGoogle Scholar
• Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech. Vasc. Interv. Radiol.7(1), 2–5 (2004).
   PubMedGoogle Scholar
• Krankenberg H, Schluter M, Steinkamp HJ et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation116(3), 285–292 (2007).
   PubMed Web of Science ®Google Scholar
• Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N. Engl. J. Med.354(18), 1879–1888 (2006).
   PubMed Web of Science ®Google Scholar
• Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J. Endovasc. Ther.12(1), 6–12 (2005).
   PubMed Web of Science ®Google Scholar
• Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J. Am. Coll. Cardiol.45(2), 312–315 (2005).
   PubMed Web of Science ®Google Scholar
• Schlager O, Dick P, Sabeti S et al. Long-segment SFA stenting – the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J. Endovasc. Ther.12(6), 676–684 (2005).
   PubMed Web of Science ®Google Scholar
• Jaff M, Dake M, Pompa J, Ansel G, Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc. Interv.70(3), 460–462 (2007).
   PubMed Web of Science ®Google Scholar
• Schillinger M, Sabeti S, Dick P et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation115(21), 2745–2749 (2007).
   PubMed Web of Science ®Google Scholar
• Duda SH, Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J. Endovasc. Ther.13(6), 701–710 (2006).
   PubMed Web of Science ®Google Scholar
• Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology223(2), 345–350 (2002).
   PubMed Web of Science ®Google Scholar
• Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J. Vasc. Interv. Radiol.14(3), 303–311 (2003).
   PubMed Web of Science ®Google Scholar
• Wiesinger B, Beregi JP, Oliva VL et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study. J. Endovasc. Ther.12(2), 240–246 (2005).
   PubMed Web of Science ®Google Scholar
• Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral–popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J. Vasc. Surg.45(1), 10–16 (2007).
   PubMed Web of Science ®Google Scholar
• Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J. Endovasc. Ther.13(3), 281–290 (2006).
   PubMed Web of Science ®Google Scholar
• Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: Part I. Circulation107(17), 2274–2279 (2003).
   PubMed Web of Science ®Google Scholar
• Grube E, Silber S, Hauptmann KE et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation107(1), 38–42 (2003).
   PubMed Web of Science ®Google Scholar
• Gallo R, Padurean A, Jayaraman T et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation99(16), 2164–2170 (1999).
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid AC et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation104(17), 2007–2011 (2001).
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid A et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation111(18), 2326–2329 (2005).
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Lansky AJ, Costa RA et al. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). Am. J. Cardiol.98(4), 464–469 (2006).
   PubMed Web of Science ®Google Scholar
• Duda SH, Bosiers M, Lammer J et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J. Vasc. Interv. Radiol.16(3), 331–338 (2005).
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) – summary of recommendations. J. Vasc. Interv. Radiol.17(9), 1383–1397 (2006).
   PubMed Web of Science ®Google Scholar
• Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J. Am. Coll. Cardiol.44(12), 2307–2314 (2004).
   PubMed Web of Science ®Google Scholar
• Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation104(17), 2057–2062 (2001).
   PubMed Web of Science ®Google Scholar
• Krankenberg H, Sorge I, Zeller T, Tubler T. Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and one-year results. Catheter. Cardiovasc. Interv.64(1), 12–17 (2005).
   PubMed Web of Science ®Google Scholar
• Balmer H, Mahler F, Do DD, Triller J, Baumgartner I. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J. Endovasc. Ther.9(4), 403–410 (2002).
   PubMed Web of Science ®Google Scholar
• Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular14(2), 63–69 (2006).
   PubMed Web of Science ®Google Scholar
• Tepe G, Zeller T, Heller S et al. Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty. Eur. Radiol.17(8), 2088–2095 (2007).
   PubMed Web of Science ®Google Scholar
• Kickuth R, Keo HH, Triller J, Ludwig K, Do DD. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J. Vasc. Interv. Radiol.18(6), 703–708 (2007).
   PubMed Web of Science ®Google Scholar
• Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J. Endovasc. Ther.12(6), 685–695 (2005).
   PubMed Web of Science ®Google Scholar
• Siablis D, Karnabatidis D, Katsanos K et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J. Endovasc. Ther.14(2), 241–250 (2007).
   PubMed Web of Science ®Google Scholar
• Commeau P, Barragan P, Roquebert PO. Sirolimus for below-the-knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc. Interv.68(5), 793–798 (2006).
   PubMed Web of Science ®Google Scholar
• Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of ‘below-the-knee’ critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J. Cardiovasc. Surg. (Torino).47(2), 171–176 (2006).
   PubMed Web of Science ®Google Scholar
• Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med.355(20), 2113–2124 (2006).
   PubMed Web of Science ®Google Scholar
• Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J. Endovasc. Ther.12(1), 1–5 (2005).
   PubMed Web of Science ®Google Scholar
• Ormiston JA, Webster MW, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc. Interv.69(1), 128–131 (2007).
   PubMed Web of Science ®Google Scholar
• Erbel R, Di Mario C, Bartunek J et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet369(9576), 1869–1875 (2007).
   PubMed Web of Science ®Google Scholar